Evolution of treatment targets in Crohn's disease

被引：4
|
作者：
White, Jonathan R. [1 ,2 ,3 ]
Jairath, Vipul [4 ,5 ]
Moran, Gordon W. [1 ,2 ,3 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England
[2] Univ Nottingham, Nottingham, England
[3] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England
[4] Western Univ, Div Gastroenterol, Dept Med, London, ON, Canada
[5] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
来源：
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2019年 / 38-39卷
关键词：
Crohn's disease; Treatment targets; Patient reported outcomes; Clinician reported activity indices; Biomarkers; Endoscopy; Imaging; Histology; INFLAMMATORY-BOWEL-DISEASE; PATIENT-REPORTED OUTCOMES; C-REACTIVE PROTEIN; POST-HOC ANALYSIS; QUALITY-OF-LIFE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; ACTIVITY INDEX; LEMANN INDEX; MAINTENANCE THERAPY;
D O I：
10.1016/j.bpg.2019.02.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Crohn's disease is a chronic relapsing and remitting inflammatory disorder of the gastrointestinal tract, associated with significantly morbidity due to both symptoms and complications that have a considerable detrimental impact on a patient's quality of life. An early treat to target approach with disease modifying agents has been shown to significantly improve long term outcomes, demonstrated by a number of therapeutic targets in a number of modalities. This review will outline the current treatment targets and measures of disease burden in Crohn's disease. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] THERAPEUTIC TARGETS FOR CROHN'S DISEASE
    Sorbera, L.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2009, 34 (06) : 491 - 499
  • [2] Commensal bacteria as targets in Crohn's disease
    Elson, CO
    GASTROENTEROLOGY, 2000, 119 (01) : 254 - 257
  • [3] The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better Drugs
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (03) : 661 - +
  • [4] Treatment of Crohn's disease
    Hoffmann, JC
    Zeitz, M
    HEPATO-GASTROENTEROLOGY, 2000, 47 (31) : 90 - 100
  • [5] Treatment of Crohn's disease
    Greenfield, S
    LANCET, 1996, 347 (9010): : 1266 - 1266
  • [6] Treatment of Crohn's disease
    Bartoska, Petr
    Paluch, Zoltan
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2022, 181 (10) : 769 - 783
  • [7] From extracellular to intracellular targets, inhibiting MAP kinases in treatment of Crohn's disease
    van den Blink, B
    ten Hove, T
    van den Brink, GR
    Peppelenbosch, MP
    van Deventer, SJH
    CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 : 349 - 358
  • [8] Emerging therapeutic targets and strategies in Crohn's disease
    Furfaro, Federica
    Fiorino, Gionata
    Allocca, Mariangela
    Gilardi, Daniela
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (06) : 735 - 744
  • [9] Treatment of Crohn's disease and familial Mediterranean fever by leukopheresis:Single shot for two targets
    Mahmut Yuksel
    Fatih Saygili
    Orhan Coskun
    Nuretdin Suna
    Mustafa Kaplan
    Ufuk Baris Kuzu
    Zeki Mesut Yalin Kilic
    Yasemin Ozderin Ozin
    Ertugrul Kayacetin
    World Journal of Gastroenterology, 2015, (13) : 4078 - 4081
  • [10] Treatment of Crohn's disease and familial Mediterranean fever by leukopheresis: Single shot for two targets
    Yuksel, Mahmut
    Saygili, Fatih
    Coskun, Orhan
    Suna, Nuretdin
    Kaplan, Mustafa
    Kuzu, Ufuk Baris
    Kilic, Zeki Mesut Yalin
    Ozin, Yasemin Ozderin
    Kayacetin, Ertugrul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 4078 - 4081
12345